Trametinib Dimethyl Sulfoxide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Trametinib Dimethyl Sulfoxide
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Trametinib Dimethyl Sulfoxide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 6 USDMF, 2 EU WC, 1 KDMF, 8 NDC API, 15 Listed Suppliers, $ API Reference Price

23 API Suppliers
6 USDMF
2 EU WC
1 KDMF
8 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

171 Drugs in Development

171 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

37 FDF Dossiers, 8 FDA Orange Book, 12 Europe, 3 Canada, 12 Australia, 2 South Africa

37 FDF Dossiers
8 FDA Orange Book
12 Europe
3 Canada
12 Australia
2 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 0.5MG, TABLET;ORAL - EQ 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2MG

TABLET;ORAL - EQ 0.5MG
TABLET;ORAL - EQ 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 2MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 5 DKSH, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 11 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 12 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 39 Fillers, Diluents & Binders, 21 Direct Compression, 19 Thickeners and Stabilizers, 19 Controlled & Modified Release, 18 Disintegrants & Superdisintegrants, 16 Granulation, 16 Solubilizers, 15 Taste Masking, 15 Chewable & Orodispersible Aids, 12 Topical, 12 Lubricants & Glidants, 10 Parenteral, 10 Co-Processed Excipients, 8 Film Formers & Plasticizers, 7 Emulsifying Agents, 6 Rheology Modifiers, 5 API Stability Enhancers, 5 Empty Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents, 4 Vegetarian Capsules

41 Coating Systems & Additives
39 Fillers, Diluents & Binders
21 Direct Compression
19 Thickeners and Stabilizers
19 Controlled & Modified Release
18 Disintegrants & Superdisintegrants
16 Granulation
16 Solubilizers
15 Taste Masking
15 Chewable & Orodispersible Aids
12 Topical
12 Lubricants & Glidants
10 Parenteral
10 Co-Processed Excipients
8 Film Formers & Plasticizers
7 Emulsifying Agents
6 Rheology Modifiers
5 API Stability Enhancers
5 Empty Capsules
4 Surfactant & Foaming Agents
4 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 49 News #PharmaBuzz

3 Data Compilation #PharmaFlow
49 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Regulatory FDF Prices, 12 Annual Reports

1 US Medicaid Prescriptions
1 Regulatory FDF Prices
12 Annual Reports

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

87 US Patents, 34 US Exclusivities, 10 Health Canada Patents

87 US Patents
34 US Exclusivities
10 Health Canada Patents

$ API Ref.Price (USD/KG) : 517,927 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

10 All

01 10Gowling WLG (Canada) LLP

filter Patent Reset all filters

10 All

01 42569850

02 32775803

03 32882437

filter Product Reset all filters

10 All

01 3TRAMETINIB

02 7Trametinib

filter Dosage Reset all filters

10 All

01 3POWDER FOR SOLUTION

02 7Tablet

filter Exp Date Reset all filters

10 All

01 42025-06-10

02 32030-10-15

03 32033-08-30

Polpharma Trametinib

Product Main Page

01

Gowling WLG (Canada) LLP

Trametinib

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Brand Name : MEKINIST

Patent Number : 2569850

Filing Date : 2005-06-10

Strength per Unit : 0.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Trametinib

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Brand Name : MEKINIST

Patent Number : 2569850

Filing Date : 2005-06-10

Strength per Unit : 1.0 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Trametinib

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Brand Name : MEKINIST

Patent Number : 2569850

Filing Date : 2005-06-10

Strength per Unit : 2.0 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling WLG (Canada) LLP

Trametinib

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-15

Date Granted : 2017-11-21

Brand Name : MEKINIST

Patent Number : 2775803

Filing Date : 2010-10-15

Strength per Unit : 0.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2030-10-15

Date Granted : 2017-11-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Gowling WLG (Canada) LLP

Trametinib

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-08-30

Date Granted : 2021-03-02

Brand Name : MEKINIST

Patent Number : 2882437

Filing Date : 2013-08-30

Strength per Unit : 0.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2033-08-30

Date Granted : 2021-03-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Gowling WLG (Canada) LLP

Trametinib

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-15

Date Granted : 2017-11-21

Brand Name : MEKINIST

Patent Number : 2775803

Filing Date : 2010-10-15

Strength per Unit : 2.0 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2030-10-15

Date Granted : 2017-11-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Gowling WLG (Canada) LLP

Trametinib

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-08-30

Date Granted : 2021-03-02

Brand Name : MEKINIST

Patent Number : 2882437

Filing Date : 2013-08-30

Strength per Unit : 2.0 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2033-08-30

Date Granted : 2021-03-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Gowling WLG (Canada) LLP

TRAMETINIB

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Brand Name : MEKINIST

Patent Number : 2569850

Filing Date : 2005-06-10

Strength per Unit : 4.7mg

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

Gowling WLG (Canada) LLP

TRAMETINIB

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-15

Date Granted : 2017-11-21

Brand Name : MEKINIST

Patent Number : 2775803

Filing Date : 2010-10-15

Strength per Unit : 4.7mg

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-10-15

Date Granted : 2017-11-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

Gowling WLG (Canada) LLP

TRAMETINIB

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-08-30

Date Granted : 2021-03-02

Brand Name : MEKINIST

Patent Number : 2882437

Filing Date : 2013-08-30

Strength per Unit : 4.7mg

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-08-30

Date Granted : 2021-03-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!